Nanomedicines to treat rare neurological disorders: The case of Krabbe disease
Thomas L. Moore(Federico II University Hospital), Venera Cardile(University of Catania), Anna Lisa Palange(Italian Institute of Technology), Miguel Ferreira(Italian Institute of Technology), Adriana Carol Eleonora Graziano(Università degli Studi di Enna Kore), Paolo Decuzzi(Italian Institute of Technology), Raffaele Spanò(Italian Institute of Technology), Gabriella Costabile(Ludwig-Maximilians-Universität München), Giovanna Pannuzzo(University of Catania)
Cited by 11
Related Papers
Nanoparticle colloidal stability in cell culture media and impact on cellular interactions
|Chemical Society Reviews|2015|1.1k
Cytosolic delivery of nucleic acids: The case of ionizable lipid nanoparticles
|Bioengineering & Translational Medicine|2021|352
Lipids and polymers in pharmaceutical technology: Lifelong companions
|International Journal of Pharmaceutics|2019|146
Mannose and Mannose‐6‐Phosphate Receptor–Targeted Drug Delivery Systems and Their Application in Cancer Therapy
|Advanced Healthcare Materials|2018|132
Hybrid Lipid/Polymer Nanoparticles to Tackle the Cystic Fibrosis Mucus Barrier in siRNA Delivery to the Lungs: Does PEGylation Make the Difference?
|ACS Applied Materials & Interfaces|2022|96